Madrigal Pharmaceuticals Inc
MDGL
Market Cap$6.34B
Close$
$153.64
48.7% downside
Current Fair Value
48.7% downsideOvervalued by 48.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $6.34 Billion |
|---|---|
| Enterprise Value | $6.16 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-21.9 |
| Beta | -1.08 |
| Outstanding Shares | 22,091,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -16.12 |
|---|---|
| PEG | 32.01 |
| Price to Sales | 23.04 |
| Price to Book Ratio | 9.36 |
| Enterprise Value to Revenue | 20.35 |
| Enterprise Value to EBIT | -15.63 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Madrigal Pharmaceuticals Inc
CEO: Rebecca Taub